Brief: Centers For Medicare & Medicaid Services Issues Preliminary Payment Rate Determination For Immunovia's Immray Pancan-D Test
26/09/2022 10:58
Sept 26 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* CENTERS FOR MEDICARE & MEDICAID SERVICES ISSUES
PRELIMINARY
PAYMENT RATE DETERMINATION FOR IMMUNOVIA'S IMMRAY PANCAN-D TEST
* CMS PUBLISHED PRELIMINARY PAYMENT DETERMINATION IMPLYING
PRICE
OF $897 FOR IMMRAY PANCAN-D TEST
Source text for Eikon: ID:nWkr7HSh8g
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study